Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

AMIKACIN SULFATE

AMIKACIN SULFATE

Standard Dose
EQ 62.5MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview AMIKACIN SULFATE is listed in Drugs@FDA under application 063283 (ANDA).

Marketing status: Discontinued Active ingredient AMIKACIN SULFATE Form and strength INJECTABLE;INJECTION - EQ 62.5MG BASE/ML Sponsor HOSPIRA Submission history Latest submission status date: 2001-04-09 00:00:00.

Structured Monograph

Clinical summary

Approval overview AMIKACIN SULFATE is listed in Drugs@FDA under application 063283 (ANDA). Marketing status: Discontinued Active ingredient AMIKACIN SULFATE Form and strength INJECTABLE;INJECTION - EQ 62.5MG BASE/ML Sponsor HOSPIRA Submission history Latest submission status date: 2001-04-09 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.